Literature DB >> 7707012

Screening for colorectal cancer: reasons for refusal of faecal occult blood testing in a general practice in England.

K A Hynam1, A R Hart, S P Gay, A Inglis, A C Wicks, J F Mayberry.   

Abstract

STUDY
OBJECTIVE: To ascertain reasons for non-compliance with faecal occult blood tests in colorectal cancer screening programmes.
DESIGN: A standard interview by a trained nurse of a random sample of those who declined screening.
SETTING: The Leicestershire town of Market Harborough, where most of the 25,000 population are served by a single general practice of 10 partners. PARTICIPANTS: Altogether 4185 residents aged 51 to 70 years were invited to receive a free faecal occult blood test (Haemoccult). Eighty one subjects from a sample of 351 who wrote declining the offer were interviewed. MAIN
RESULTS: Non-compliers were divided into those who did not request a test kit and those who returned an unused kit. In the former group the commonest reasons given were intercurrent illness (39%), fear of further tests and surgery (24%), and feeling well (22%). For those who returned unused kits the commonest reasons were the unpleasantness of the stool collection procedure (65%), feeling well (30%), intercurrent illness (23%), and fear of further tests and surgery (20%). In both groups the main concern of those who did not comply were fear of further diagnostic tests and surgery rather than concern at the lack of effective treatment for cancer.
CONCLUSIONS: To increase compliance, education and publicity must explain the concept of asymptomatic illness and allay people's fear of hospital investigation and treatment. The benefits of screening should be particularly emphasised to those who return kits so they may overcome their reservations.

Entities:  

Mesh:

Year:  1995        PMID: 7707012      PMCID: PMC1060080          DOI: 10.1136/jech.49.1.84

Source DB:  PubMed          Journal:  J Epidemiol Community Health        ISSN: 0143-005X            Impact factor:   3.710


  17 in total

1.  Participation in mass screening for colorectal cancer with fecal occult blood test.

Authors:  K Klaaborg; M S Madsen; O Søndergaard; O Kronborg
Journal:  Scand J Gastroenterol       Date:  1986-12       Impact factor: 2.423

2.  Factors affecting compliance with screening for colorectal cancer.

Authors:  P A Farrands; J D Hardcastle; J Chamberlain; S Moss
Journal:  Community Med       Date:  1984-02

3.  Attitudes of non-participants in an occupational based programme of screening for colorectal cancer.

Authors:  A Silman; P Mitchell
Journal:  Community Med       Date:  1984-02

4.  Faecal occult blood testing for colorectal cancer in general practice.

Authors:  R Million; J Howarth; E Turnberg; L A Turnberg
Journal:  Practitioner       Date:  1982-04

5.  Assessment of attitudes toward mass screening for colorectal cancer and polyps.

Authors:  M H Spector; W B Applegate; S J Olmstead; P V DiVasto; B Skipper
Journal:  Prev Med       Date:  1981-01       Impact factor: 4.018

6.  The evolution of cancer of the colon and rectum.

Authors:  T Muto; H J Bussey; B C Morson
Journal:  Cancer       Date:  1975-12       Impact factor: 6.860

7.  Natural history of untreated colonic polyps.

Authors:  S J Stryker; B G Wolff; C E Culp; S D Libbe; D M Ilstrup; R L MacCarty
Journal:  Gastroenterology       Date:  1987-11       Impact factor: 22.682

8.  Predicting colon cancer screening behavior from health beliefs.

Authors:  F A Macrae; D J Hill; D J St John; A Ambikapathy; J F Garner
Journal:  Prev Med       Date:  1984-01       Impact factor: 4.018

9.  Screening for asymptomatic bowel cancer in general practice.

Authors:  R C Lallemand; P A Vakil; P Pearson; V Box
Journal:  Br Med J (Clin Res Ed)       Date:  1984-01-07

10.  Progress report on controlled trial of fecal occult blood testing for the detection of colorectal neoplasia.

Authors:  S J Winawer; M Andrews; B Flehinger; P Sherlock; D Schottenfeld; D G Miller
Journal:  Cancer       Date:  1980-06-15       Impact factor: 6.860

View more
  10 in total

1.  The effect on compliance of a health education leaflet in colorectal cancer screening in general practice in central England.

Authors:  A R Hart; T L Barone; S P Gay; A Inglis; L Griffin; C A Tallon; J F Mayberry
Journal:  J Epidemiol Community Health       Date:  1997-04       Impact factor: 3.710

2.  Colorectal cancer prevention. An approach to increasing compliance in a faecal occult blood test screening programme.

Authors:  A R Hart; J Eaden; S Barnett; A M de Bono; J F Mayberry
Journal:  J Epidemiol Community Health       Date:  1998-12       Impact factor: 3.710

3.  Low adherence to colonoscopy in the screening of first-degree relatives of patients with colorectal cancer.

Authors:  Luis Bujanda; Cristina Sarasqueta; Leire Zubiaurre; Angel Cosme; Carmen Muñoz; Araceli Sánchez; Cristina Martín; Llucia Tito; Virginia Piñol; Antoni Castells; Xavier Llor; Rosa M Xicola; Elisenda Pons; Juan Clofent; María L de Castro; Jaime Cuquerella; Enrique Medina; Ana Gutierrez; Juan I Arenas; Rodrigo Jover
Journal:  Gut       Date:  2007-03-30       Impact factor: 23.059

4.  The cost-effectiveness of CT colonography in screening for colorectal neoplasia.

Authors:  Sandeep Vijan; Inku Hwang; John Inadomi; Roy K H Wong; J Richard Choi; John Napierkowski; Jonathan M Koff; Perry J Pickhardt
Journal:  Am J Gastroenterol       Date:  2006-12-11       Impact factor: 10.864

5.  Colorectal cancer screening in older men and women: qualitative research findings and implications for intervention.

Authors:  C Beeker; J M Kraft; B G Southwell; C M Jorgensen
Journal:  J Community Health       Date:  2000-06

6.  Public acceptability of a technology-mediated stool sample collection platform to inform community-based surveillance of infectious intestinal disease: a pilot study.

Authors:  Rowan Davies; Miren Iturriza-Gómara; Rebecca Glennon-Alty; Alex J Elliot; Roberto Vivancos; Anica Alvarez Nishio; Nigel A Cunliffe; Daniel Hungerford
Journal:  BMC Public Health       Date:  2022-05-13       Impact factor: 4.135

7.  An industry based approach to colorectal cancer screening in an asymptomatic population.

Authors:  A R Hart; N Glover; J Howick-Baker; J F Mayberry
Journal:  Postgrad Med J       Date:  2003-11       Impact factor: 2.401

8.  Knowledge and attitudes of primary health care physicians and nurses with regard to population screening for colorectal cancer in Balearic Islands and Barcelona.

Authors:  Maria Ramos; Magdalena Esteva; Jesús Almeda; Elena Cabeza; Diana Puente; Rosa Saladich; Albert Boada; Maria Llagostera
Journal:  BMC Cancer       Date:  2010-09-20       Impact factor: 4.430

9.  Patients' perspectives on providing a stool sample to their GP: a qualitative study.

Authors:  Donna M Lecky; Meredith K D Hawking; Cliodna A M McNulty
Journal:  Br J Gen Pract       Date:  2014-11       Impact factor: 5.386

10.  Responses to procedural information about colorectal cancer screening using faecal occult blood testing: the role of consideration of future consequences.

Authors:  Christian von Wagner; Anna Good; Samuel G Smith; Jane Wardle
Journal:  Health Expect       Date:  2011-04-19       Impact factor: 3.377

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.